Request a call

Cancer vaccine

Personalized immunotherapy at affordable prices

Learn more

Relevance of the disease

According to WHO, about 14 million cancer cases are diagnosed annually in the world. By 2030, this figure may increase to 21 million. Cancer shortens the life expectancy of the male population by 3.6 years, and the female population by 2.5 years. On average, cancer patients live 17-18 years less than people who do not suffer from malignant tumors, and 40% of this time falls on working age.

Cancer is a disease that affects various organs and systems. One of the main features of malignant pathology is the rapid formation of abnormal cells, which subsequently spread throughout the body.

About the vaccine

15
Years of experience
5
Clinical researches
10
Ukrainian patents
1000+
Cancer patients who have undergone treatment

The goal of vaccine therapy is to slow down the progression or prevent the recurrence of the malignant process.

In recent years, immunotherapy has become a real breakthrough in cancer treatment. In Europe and Japan, therapeutic anticancer vaccines are actively being developed, the purpose of which is to mobilize the entire “army” of the immune system.

Dendritic cell vaccines against cancer have demonstrated high efficiency in this regard. They have a more pronounced effect than other types of antitumor vaccines, as dendritic cells are the “generals” of the army of the immune system.

The vaccine makes it possible to improve the indicators of standard cancer treatment by 30-40%, reduce the risk of relapse and metastasis, and also improve the quality of life of cancer patients.

Learn more

Action principle

The vaccine is made individually for each patient. To do this, blood from the patient, from which dendritic cells are isolated, and a tumor sample are taken, which is necessary for the activation of the immune system against a certain type of cancer.

After the vaccine is administered, dendritic cells transmit the necessary information to lymphocytes, and a rapid immune response develops in the body. This allows the body to slow down the progression, and in some cases to completely stop the malignant process.

Learn more

Advantages

01
Scientifically proven clinical efficiency
02
Personalized approach to cancer treatment
03
Low level of side effects and possible complications
04
Improvements in standard cancer treatment
05
The ability to significantly extend and improve the quality of life

Who is suitable

Treatment with cancer vaccine Cancerax is prescribed to patients with various types of malignant neoplasms in the early stages of development. Tumor material is required to undergo vaccine therapy. It can be a recently removed neoplasm or a sample of malignant tissue preserved in the right conditions. If it is not possible to obtain a sample, for some types of cancer it is possible to isolate circulating tumor cells from the bloodstream.

The use of the Cancerax dendritic cell vaccine as part of complex therapy allows for minimizing the likelihood of disease recurrence, thereby ensuring a high level of patient survival.

The greatest efficiency can be achieved in the treatment of:

  • Melanomas;
  • Brain cancer;
  • Head and neck cancer;
  • Lung cancer;
  • Breast cancer;
  • Stomach cancer;
  • Pancreatic cancer;
  • Cancer of the large and small intestines;
  • Kidney cancer;
  • Ovarian cancer;
  • Bladder cancer.

Efficiency

Clinical trials conducted between 1980 and 2003 showed that the use of an anticancer vaccine in combined cancer treatment significantly improves the 5-year survival rate and improves the quality of life of cancer patients. To achieve the greatest effectiveness of vaccine therapy, it is recommended to undergo 5 courses of treatment.

Compared to standard treatment, complex therapy with the use of the Cancerax vaccine allows increasing patients survival by:

40%
Kidney cancer
5-year survival
15%
Ovarian cancer
5-year survival
35%
Lung cancer
5-year survival
22%
Pancreatic cancer
2-year survival

Frequently asked questions

What are dendritic cells?
Scientists call dendritic cells "conductors of the immune orchestra". Without them, the formation of an immune response according to the antigenic type is impossible. It is dendritic cells that break down cancer cells into smaller parts – antigens, after which they present ("show") them to T-lymphocytes, which attack the tumor. The main difficulty in treating cancer is that the tumor triggers mechanisms that hide it from the immune system. And one of these mechanisms is the inhibition of dendritic cells. To preserve their function, doctors isolate dendritic progenitor cells from the patient's blood and grow them in the laboratory. After that, they "teach" the dendritic cells to recognize the tumor and inject them back into the patient's bloodstream.
Why is there so little information about the vaccine?
In fact, there is a lot of information. For more than 15 years of development experience in the field of cell therapy, scientists have: conducted 5 extensive clinical studies involving more than 1000 cancer patients; received 10 Ukrainian patents; defended 3 candidates and 3 doctoral dissertations; published more than 200 scientific works in prestigious medical journals. The developments were highly appreciated at numerous international forums. Vaccine therapy with the Ukrainian drug is a progressive method of treatment with clinically proven effectiveness.
Is vaccine therapy safe?
Compared to other forms of cancer treatment, such as chemotherapy or radiotherapy, the use of the vaccine is practically not associated with the development of side effects. If they do occur, they are due to the activation of the immune system. It can be a slight increase in body temperature and general malaise. As a rule, adverse reactions pass quickly and do not require specialized treatment. Therefore, vaccine therapy with dendritic cells can be carried out in combination with other antitumor techniques.
Can I receive the vaccine if I don't have a tumor tissue sample?
In priority, the vaccine is made using tumor material. However, not all patients are able to provide it. Some of them had surgery to remove the tumor a long time ago or have contraindications to surgery. However, even in such cases, vaccine treatment is still possible. Specialized equipment makes it possible to isolate circulating tumor DNA or the tumor cells themselves from the bloodstream.
Does vaccine therapy help prevent cancer recurrence?
After the vaccine is administered, dendritic cells present tumor antigens to T-lymphocytes, after which they gain the ability to recognize and kill cancer cells. "Trained" T-lymphocytes actively multiply and spread throughout the body. Since they remain active for a long period, vaccine therapy is an effective method of preventing cancer recurrence after standard treatment.
How quickly is an individual cancer vaccine made?
The vaccine is made within 8 days. This period is necessary for the development of mature dendritic cells from progenitor cells. In the process of maturation, they are "loaded" with tumor antigens, which will later be needed for the formation of an immune response.
How is the vaccine given? Do I need to go to the hospital?
The way the vaccine is administered depends on the type of tumor the patient is applying for. For example, in the treatment of lung cancer, intravenous administration is more effective. For other oncological diseases, subcutaneous injections are performed. Since vaccine therapy is not associated with severe side effects, treatment is carried out on an outpatient basis.
Can I combine vaccine treatment with chemotherapy or radiotherapy?
Vaccine treatment does not replace standard cancer treatment and is carried out exclusively as part of combined therapy. If you are currently undergoing chemotherapy or radiotherapy, your doctor will tell you when is the best time to start treatment with the vaccine.
Will I get worse after being treated with the vaccine?
In clinical trials involving more than 1000 patients, not a single case of an increase in the intensity of tumor growth was noted. Moreover, some patients after the introduction of the vaccine note a general improvement in well-being, as well as an increase in resistance to cold diseases.
Is vaccine treatment right for me?
The drug is used to treat most types of cancer. To find out whether treatment is possible in your particular case, leave a request on the website. A medical coordinator will contact you to answer your questions.

Are you a doctor?

Do you want your patients to take a course of vaccine therapy? Leave a request and we will contact you!

Learn more

Types of vaccine

Auto

If you are planning an operation and want to protect yourself from a recurrence of the disease, you can use an anti-cancer autovaccine created based on your malignant cells. Such a vaccine is most effective for the complete treatment of cancerous tumors.

Learn more
Xeno

If you have had surgery to remove a tumor a long time ago and do not have a sample of tumor tissue to create an autovaccine, undergo treatment with Xeno immunotherapy – a xenogeneic vaccine that helps activate the immune system to fight cancer cells.

Its use is also suitable for patients who belong to the risk group and want to protect themselves from cancer development in the future.

Learn more

Our contacts

We are always happy to help you.

Fill in your details to receive a free consultation.



    Оставляя данные на сайте, Вы соглашаетесь с нашей Политикой конфиденциальности и защиты данных.